Solid Biosciences (SLDB) Profit After Tax Growth (3y) (2020 - 2026)
Solid Biosciences (SLDB) Profit After Tax Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
33.21% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
30.60% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-154.28% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
16.53% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Solid Biosciences |
789.54 Mn |
408.86 Mn |
- |
-23.57% |
| Date | Value |
|---|
| Mar 31, 2026 |
-23.57% |
| Dec 31, 2025 |
-48.65% |
| Sep 30, 2025 |
-30.90% |
| Jun 30, 2025 |
-16.31% |
| Mar 31, 2025 |
-15.75% |
| Dec 31, 2024 |
-31.79% |
| Sep 30, 2024 |
-22.09% |
| Jun 30, 2024 |
-10.28% |
| Mar 31, 2024 |
-12.87% |
| Dec 31, 2023 |
1.65% |
| Sep 30, 2023 |
0.42% |
| Jun 30, 2023 |
-9.06% |
| Mar 31, 2023 |
-4.05% |
| Dec 31, 2022 |
21.95% |
| Sep 30, 2022 |
11.31% |
| Jun 30, 2022 |
1.83% |
| Mar 31, 2022 |
5.04% |
| Dec 31, 2021 |
5.31% |
| Sep 30, 2021 |
1.85% |
| Jun 30, 2021 |
-1.31% |
